Genor Biopharma Holdings Limited (6998.HK) HKSE

2.51

+0.1(+4.15%)

Updated at January 14 04:08PM

Currency In HKD

Valuation

Market Cap834.42M
Enterprise Value-223.46M
P/E Ratio58.04
PEG Ratio0.41
Price/Sales Ratio5.22
Price/Book Ratio1.06
Enterprise/Revenue0.71
Enterprise/EBITDA15.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.09
Operating Margin-0.04

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue206.23M
Revenue/Share0.43
Gross Profit204.89M
EBITDA-5.15M
Net Income-51.28M
Diluted EPS-0.1

Balance Sheet

Total Cash1.01B
Total Cash/Share1.94
Total Debt745,000
Total Debt/Equity0
Current Ratio4.93
Book Value Per Share2.11

Price History

52-Week Change39.44
52-Week High3.14
52-Week Low2.38
Moving Average 50 Days2.76
Moving Average 200 Days2.76

Statistics

Average Volume1.62M
Shares Outstanding521.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A